Amyotrophic Lateral Sclerosis Blog
Includes: ALS (amyotrophic lateral sclerosis), Amyotrophic Lateral Sclerosis (ALS), Lou Gehrig's Disease, Motor Neurone Disease, ALS
Join the 'Amyotrophic Lateral Sclerosis' group to help and get support from people like you.
Finding Raises Hope for Treating ALS
Posted 3+ months ago by Drugs.com
MONDAY, JUNE 15 – Researchers now believe that ALS, or amyotrophic lateral sclerosis, starts well before its debilitating symptoms appear, a finding that they say could eventually lead to an effective treatment.
Protein clumps in cells that show up only after damage has occurred, rather than at the onset of the disease, appear responsible for the paralyzing course of ALS (amyotrophic lateral sclerosis), according to University of Florida researchers.
The research team found that the formation of these clumps of defective proteins and cell matter, called "protein aggregates," actually signals that ALS is progressing at a rapid pace. Read more...
Related support groups: Amyotrophic Lateral Sclerosis
Gene Mutation Linked to Inherited ALS
Posted 3+ months ago by Drugs.com
THURSDAY, Feb. 26 – A new gene has been identified as playing a role in the inherited form of amyotrophic lateral sclerosis, or ALS, say researchers at the University of Massachusetts Medical School and King's College, London.
The discovery, a mutation in the FUS/TLS gene, is the fourth gene linked to the neurological disorder, also known as Lou Gehrig's disease. The finding was reported in the Feb. 27 issue of the journal Science. Read more...
Related support groups: Amyotrophic Lateral Sclerosis
Growth Hormone Won't Fight ALS
Posted 3+ months ago by Drugs.com
MONDAY, Nov. 24 – The growth hormone known as insulin-like growth factor-1 (IGF-1) showed no benefit for people with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
The two-year U.S. study included 330 patients from 20 medical centers.
Two previous, shorter studies had produced conflicting results. One North American study found that IGF-1 was beneficial, while a European study found no benefit for people with ALS, a progressive, fatal neurodegenerative disease that causes muscles to weaken and deteriorate.
This new study concluded that IGF-1 does not slow progression of muscle weakness. Read more...
Related support groups: Amyotrophic Lateral Sclerosis
Ask a Question
You may also be interested in...
Related Condition Support Groups
Central Nervous System Disorders
